Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Saimo Pharmaceutical is a comprehensive Contract Development and Manufacturing Organization (CDMO) based in Quzhou, China. The company specializes in the development and large-scale production of small molecule intermediates, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including oral solids and sterile injections. Zhejiang Saimo operates state-of-the-art facilities designed to meet international GMP standards, serving both domestic and global pharmaceutical clients. Their service offerings span from process R&D and pilot-scale production to commercial-scale manufacturing, utilizing advanced automation and smart factory technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Saimo Pharmaceutical.